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Role of endometrial immune cells in implantation
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Department of Obstetrics and Gynecology, Konyang University Hospital, Daejeon, Korea
Implantation of an embryo occurs during the mid-secretory phase of the menstrual cycle, known as the “implantation window.” During this im-
plantation period, there are significant morphologic and functional changes in the endometrium, which is followed by decidualization.  Many 
immune cells, such as dendritic and natural killer (NK) cells, increase in number in this period and early pregnancy. Recent works have revealed 
that antigen-presenting cells (APCs) and NK cells are involved in vascular remodeling of spiral arteries in the decidua and lack of APCs leads to 
failure of pregnancy. Paternal and fetal antigens may play a role in the induction of immune tolerance during pregnancy. A balance between 
effectors (i.e., innate immunity and helper T [Th] 1 and Th17 immunity) and regulators (Th2 cells, regulatory T cells, etc.) is essential for estab-
lishment and maintenance of pregnancy. The highly complicated endocrine-immune network works in decidualization of the endometrium 
and at the fetomaternal interface. We will discuss the role of immune cells in the implantation period and during early pregnancy.
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Introduction
The endometrium is the site where the blastocyst is implanted and 
a key place not only for supporting fetal growth through supplemen-
tation of oxygen and nutrients but also for protecting the embryo 
and later the fetus from microbial invasion during pregnancy. Implan-
tation of the embryo occurs during the mid-secretory phase of the 
menstrual cycle, known as the “implantation window.” During this im-
plantation period, there are significant morphologic and functional 
changes in the endometrium, which is followed by decidualization. 
These events in the endometrium are mainly controlled by ovarian 
steroid hormones-estrogen and progesterone [1]. 
The uterine endometrium consists of two main cellular components, 
the stromal cells and the glandular cells. During the implantation win-
dow, the fibroblast-like endometrial stromal cells are transformed into 
larger and rounded decidual cells (decidualization). In the glandular 
cells, secretory glandules develop and large apical protrusions (pinop-
odes) and microvilli emerge as well [2]. Furthermore, ovarian steroid 
hormones regulate the expression of various cytokines, chemokines, 
growth factors, and adhesion molecules in the secretory endometri-
um [1]. 
Around the implantation period, there is a major change in the pro-
portion and number of endometrial immune cells [3,4]. This peri-im-
plantation period seems to be the earliest period in which the moth-
er can recognize that she is pregnant [5]. The serum hCG concentra-
tion increases during this period, and it is likely that the maternal im-
mune cells recognize fetal antigens from the implantation period [6]. 
It is now widely accepted that immunologic tolerance is inevitable 
for establishment and maintenance of pregnancy [7]. 
In this article, the role of immune cells in the endometrium of peri-
implantation period and following period will be discussed.
Peripheral blood and endometrial lymphocytes 
during a menstrual cycle
It has been reported that the number and proportion of immune 
cells in the peripheral blood and endometrium change between the 
follicular and luteal phases of the ovarian cycle. However, exact fig-
ures on the fluctuation of peripheral blood lymphocytes remain un-
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known due to the contradictory results of different studies [8,9]. 
Recently, our group published a relatively large-scale study that was 
designed to sample peripheral blood serially during a menstrual cy-
cle [10]. In the luteal phase, the percentage of CD3
+ T and CD3
+CD4
+ 
helper T (Th) cells decreased, but the natural killer (NK) cell percent-
age and NK cell cytotoxicity increased. However, other lymphocyte 
subpopulations (B and natural killer T [NKT] cells) and the ratios of 
Th1/Th2 cytokines producing Th cells did not fluctuate. One impor-
tant characteristic of peripheral blood immune cells is that they have 
been suggested as a major source of endometrial immune cells. 
Dendritic cells and macrophages in the 
endometrium and decidua
Dendritic cells (DCs) and macrophages, the major antigen present-
ing cells in the endometrium, seem to play an important role in the 
maintenance of pregnancy. After implantation of a blastocyst, DCs are 
recruited into the endometrium and accumulated, especially around 
the implanted embryo [11]. In the deciduae, DCs represent around 
5-10% of all hematopoietic uterine cells. DCs are not only essential 
for the induction of primary immune responses but also important 
for the induction of immunological tolerance. The function and dif-
ferentiation of DCs are regulated by the local microenvironment de-
termined by cytokines and chemokines [11]. Levels of colony-stimu-
lating factor (CSF)-1 synthesized by the uterine epithelium increase 
at the time of implantation and continue to elevate dramatically 
throughout the process of placentation [12]. This CSF-1 is the major 
regulator of the mononuclear phagocytic lineage and controls the 
proliferation, migration, viability, and function of DCs and macro-
phages and affects decidual cells and trophoblasts (Figure 1) [12]. 
Endometrial epithelial cells produce leukemia inhibitor factor (LIF) as 
well as CSF-1. LIF plays a role in embryo implantation and decidual-
ization. DCs secrete soluble FMS-like tyrosine kinase1 (sFLT1) and 
transforming growth factor (TGF)-β1, which act locally and regulate 
angiogenesis in the endometrium and are involved in the develop-
ment of regulatory T (Treg) cells (Figure 2) [12]. 
In a study done in pregnant mice, depletion of uterine DCs resulted 
in the severe impairment of the implantation process, leading to em-
bryo resorption [11]. The authors suggested that uterine DCs directly 
fine-tune decidual angiogenesis by providing two critical factors, sFlt1 
and TGF-β1, that promote coordinated blood vessel maturation. Col-
lectively, uterine DCs appear to govern uterine receptivity, indepen-
dent of their predicted role in immunological tolerance, by regulat-
ing tissue remodeling and angiogenesis [11]. 
Macrophages are the innate immune cells that eliminate microbes 
in the endometrium. The number of endometrial macrophages in-
creases in the late secretory endometrium as compared to the prolif-
erative phase [13]. Decidual macrophages can participate in diverse 
activities during pregnancy [14]. Decidual macrophages comprise 
about 20-25% of the total decidual leukocytes and are the main sub-
set of human leukocyte antigen (HLA)-DR
+ antigen-presenting cells 
(APCs) in human deciduae [14]. 
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Figure 2. Proposed roles of uterine dendritic cells (DCs) in the regula-
tion of angiogenesis and T cell action at the maternal-fetal interface. 
Monocytes are recruited to the uterus and differentiate into mature 
tolerogenic cells such as uDCs, under the influence of colony-stimu-
lating factor (CSF-1), GM-CSF, and interleukin (IL)-4. Uterine DCs pro-
duce soluble FMS-like tyrosine kinase 1 (sFLT1) and transforming 
growth factor (TGF)-β1. sFLT1, a soluble form of  VEGFR1, modulates 
the actions of vascular endothelial growth factor (VEGF), and TGF-β1 
influences endothelial cell viability and suppresses cytotoxic CD8
+ T 
cell function and development of regulatory T (Treg) cells ( Modified 
from Pollard JW. J Clin Invest 2008;118: 3832-5 [12]).
Figure 1. Role of dendritic cells (DCs) and macrophages in implanta-
tion. Ovarian steroid hormones, E2, and progesterone (P4) stimulate 
synthesis of growth factors from endometrial epithelial cells, includ-
ing colony-stimulating factor (CSF-1) and leukemia inhibitor factor 
(LIF). Uterine DCs are required for efficient decidualization of the en-
dometrium. Macrophages play a largely immune role at this stage 
(Modified from Pollard JW. J Clin Invest 2008;118:3832-5 [12]). TGF, 
transforming growth factor; sFLT,  soluble FMS-like tyrosine kinase. 
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Decidual macrophages activated by pro-inflammatory cytokines 
and microbial lipopolysaccharide (LPS) are classified as M1-type, 
which secretes tumor necrosis factor (TNF)-α and interleukin (IL)-12 
and participates in the progression of inflammation [14]. M2 polar-
ization induced by glucocorticoids and Th2 cytokines such as IL-4, IL-
10, and IL-13 is characterized by enhanced innate immunity recep-
tors (scavenger receptors and macrophage mannose receptors) and 
upregulation of arginase activity, which counteracts nitric oxide syn-
thesis [14]. In addition, M2 macrophages demonstrate increased se-
cretion of IL-1R antagonist and are essential for tissue remodeling and 
immune tolerance during pregnancy (Figure 3) [14]. In early preg-
nancy, pro-angiogenic factors secreted from macrophages prompt 
vascular remodeling to ensure appropriate utero-placental circula-
tion. In contrast, macrophages accumulated in the low uterine seg-
ment participate in cervical ripening during late pregnancy [14]. A 
balance of M1 and M2 macrophages may contribute to the outcome 
of pregnancy.
T cells in the endometrium and deciduae
Some authors have reported that the proportion of endometrial 
lymphocytes was not found to fluctuate during a menstrual cycle 
[15]. However, this finding is not supported by others, who found a 
significant decrease of endometrial T cells from 55% to 6.7% between 
the late proliferative and the late secretory phages [4]. Even though 
there is a discrepancy regarding the proportion of T cells in the secre-
tory endometrium, functional changes of T cells in the endometrium 
are evident. The balance between effector T and regulatory T cells 
may change from the peri-implantation period. This balance is very 
important for fetomaternal immune tolerance, the essential mecha-
nism for a successful pregnancy. 
1. Type1 and Type2 cytokine producing T cells
During pregnancy, type 1 (pro-inflammatory immune reaction me-
diated by TNF-α, IFN-γ, etc.) and type 2 (anti-inflammatory response 
characterized by IL-4, IL-10, etc.) immune reactions develop sequen-
tially [16]. The process of embryo implantation and the following in-
vasion into the endometrium is characterized by a pro-inflammatory 
reaction [16]. The second phase of rapid fetal growth and develop-
ment represents an anti-inflammatory, Th2 environment. The end 
stage of pregnancy, parturition, is the phase of inflammation charac-
terized by an influx of immune cells into the myometrium.
Even though the number of T cells present in the decidua decreases 
during pregnancy as compared to the non-pregnant endometrium, 
these T cells may affect acceptance of the fetus by producing cyto-
kines [7]. It is well known that a strong Th1 environment is harmful 
for pregnancy and the Th2 response ameliorates the Th1 response 
[7]. Type 1 cytokines inhibit trophoblast invasion, stimulate apoptosis 
of human trophoblast cells, and enhance decidual macrophage ac-
tivity, all of which result in the production of factors harmful to the 
embryo. Also, these cytokines negatively influence fetal growth by 
activation of prothrombinase, generation of thrombin, formation of 
clots, and production of IL-8, which stimulates granulocyte and en-
dothelial cells to terminate the blood supply to the developing pla-
centa [7]. 
2. γδ T cells
T cells can be classified by the expression of T cell receptor (TCR): 
TCR is composed of a combination of α, β, and ζ chains. Most T cells 
have TCRs with α and β chains. However, some T cells-γδ T cells-do 
have TCRs made up of γ and δ chains, not of α and β ones. These two 
T cell subsets seem to have distinct lineages and play different roles. 
γδ T cells are commonly distributed in the mucosal organs, such as 
the uterus, the vagina, the tonsils, and the intestine, and may play a 
role in bridging the innate and adaptive immunity. Nearly 70% of de-
cidual T cells express γδ TCRs and most γδ T cells are activated [17]. 
The majority of progesterone receptor (PR)
+lymphocytes are γδ TCRs
+ 
and/or CD8
+ T cells, and these PR
+ lymphocytes in the peripheral 
blood increase in number during normal pregnancy. PR expression is 
regulated in a hormone-independent manner and is upregulated by 
activation of these lymphocytes. Furthermore, lymphocyte immuno-
therapy for recurrent miscarriages has been shown to induce lym-
phocyte PRs and has shown that these are related to the success or 
failure of gestation [17]. It is suggested that γδ T cells can recognize 
trophoblast-presented antigens [17]. 
Figure 3. Molecular mechanisms associated with the two distinctive 
macrophage phenotypes in the deciduae. Mo, monocyte; TLR, toll-
like receptor; iNOS, inducible NO synthase; NO, nitric oxide; IDO, in-
doleamine dioxygenase; COX2, cyclooxygenase 2; PGE2, prostaglan-
din E2; IL, interleukin; TNF, tumor necrosis factor (Modified from Na-
gamatsu T, et al. Am J Reprod Immunol 2010;63:460-71 [14]).
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It is reported that progesterone-induced blocking factor (PIBF) is 
produced by activated lymphocytes and trophoblasts. PIBF downreg-
ulates Th1 cytokines, stimulates Th2 cytokines and antibody synthe-
sis, and inhibits NK cell activity and phospholipase A2 in arachidonic 
acid metabolism [17]. 
In summary, γδ T cells are likely to be activated by recognition of fe-
tal antigens, and activated γδ T cells produce PIBF under the influence 
of progesterone. PIBF induces a Th2 dominant microenvironment, in-
hibits NK cell cytotoxicity, and maintains uterine quiescence by block-
ing prostaglandin synthesis. 
3. Treg cells
There are several types of immune regulatory T lymphocytes: Tr1 
cells (IL-10 producing T cells), Th3 cells (TGF-β secreting T cells), TofB 
cells (regulatory T cells stimulated by B cells), and Foxp3
+ Treg cells 
[18,19]. Among these cells, Foxp3
+ Treg cells have been most exten-
sively studied and most of them correspond to CD4
+CD25
bright T cells. 
There are two distinct lineages of Foxp3
+ Treg cells. One lineage, 
nTreg cells, originates from the thymus. The other, iTreg cells, is known 
to be induced in the periphery by activation of naïve T cells in the 
presence of TGF-β. Foxp3
+ Treg cells can be activated by APCs and 
play a role in immune regulation against other immune cells such as 
Th1 and Th2 cells, B cells, and NK cells by expression of TGF-β, IL-10, 
cytotoxic T-lymphocyte antigen 4 (CTLA-4), etc. [20]. 
Even though there is no report showing a change in the number of 
Treg cells in the midluteal phase of the menstrual cycle, Treg cells in-
creased in the peripheral blood during normal pregnancy [21]. In a 
study in women with recurrent pregnancy loss (RPL), Treg cells de-
creased in the peripheral blood and in the decidua as compared to 
those of women underwent elective abortion [22]. These findings in-
dicate that Treg cells may be deeply involved in maternal immune 
tolerance against a fetus. 
Some papers have insisted that estrogen is a key factor in the prolif-
eration of Treg cells in the late follicular phase or during pregnancy 
[23,24]. According to recent studies, however, expansion of Treg cells 
during pregnancy is relevant to exposure to paternal antigen or prod-
ucts such as sperm and factors in the seminal fluid, but not to estro-
gen or progesterone [25-27]. 
Interestingly, hCG may have a role in the recruitment of Treg cells 
into the uterus during pregnancy [28]. It remains unclear how Treg 
cells protect a fetus in the uterus. One explanation is that Treg cells 
may expand following recognition of paternal antigens, and are traf-
ficked to the fetomaternal interface by hCG and several chemokines, 
where they help embryo implantation, placentation, and fetal growth 
by secretion of TGF-β, IL-10, LIF, Heme oxygenase (HO)-1, etc. [28] 
(Figure 4). 
4. Th17 cells
Recently, a novel subset of T cells called Th17 cells has been reported 
to induce experimental autoimmune encephalomyelitis and adjuvant 
arthritis in a mouse model [29,30]. Th17 cells are directly involved in 
chronic inflammatory processes by secreting IL-17, which recruits 
neutrophils to tissue through induction of granulocyte colony-stimu-
lating factor and IL-8 [31]. Th17 cells have a distinct developmental 
lineage, which is different from Th1 and Th2 cells [29,32]. TGF-β has 
been suggested as a crucial cytokine for Th17 cell development, in 
conjunction with IL-6 and IL-21 in human [33-36]. Th17 cells are main-
ly regulated by Treg cells. 
The level of Th17 cells in the endometrium at various points in time 
during a menstrual cycle remains unexplored. A recent study report-
ed that the proportions of Th17 cells in the peripheral blood and de-
ciduae were higher in pregnant women with unexplained RPL as 
compared to normal women in early pregnancy [37]. Non-pregnant 
women with unexplained RPL had a higher Th17 cell level in the cir-
culating blood than did parous controls [38].
B cells in the endometrium and decidua
B cells are very scarce in the human endometrium and decidua [14]. 
Their role has not yet been explored.
NK cells in the endometrium and decidua
NK cells are one of the key components of the innate immune sys-
tem and eliminate virus-infected cells and cancer cells by secretion of 
cytotoxic products such as granzyme and perforin. Endometrial NK 
cells show different phenotypic characteristics from NK cells in the 
Figure 4. Possible mechanisms of the origin, expansion, migration, 
and function of Treg cells during pregnancy. APC, antigen presenting 
cells; TGF-β, transforming growth factor-β; IL, interleukin; LIF, leuke-
mia inhibitor factor; HO-1, heme-oxygenase-1 (Modified from Leber 
A, et al. Am J Reprod Immunol 2010;63:445-59 [28]).
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peripheral blood. Peripheral blood NK cells represent 10-15% of all 
lymphocytes, and the majority of them express CD56
+CD16
+, a cyto-
toxic subset. On the other hand, most endometrial NK cells are 
CD56
+CD16
−, a less toxic cell population. During a menstrual cycle, 
endometrial NK cells increase in number in the secretory phase as 
compared to the proliferative phase [39]. However, the proportion of 
human endometrial NK cells remains constant during the cycle [15]. 
In the late secretory phase and early pregnancy, the percentage of 
endometrial/decidual NK cells rapidly increases up to 70% of uterine 
leukocytes [4]. The number of endometrial and decidual NK cells starts 
to increase in the mid-secretory phase and early pregnancy, reaches 
a peak at the end of the first trimester, and then decreases as the fe-
tus approaches term (Figure 5) [39]. These findings suggest that uter-
ine NK cells play an important role in the establishment and mainte-
nance of pregnancy. 
Most endometrial NK cells of non-pregnant women do not express 
CD16 (a cytotoxicity marker), NKp30, NKp44 (cell activation markers), 
or L-selectin (an adhesion molecule) [40]. However, they are charac-
terized by expression of other activation markers such as HLA-DR, 
CD69, NKp46, and NKG2D. NK cells at this stage are functionally less 
cytotoxic and produce little amount of cytokines. However, secretory 
endometrial NK cells have the potential to proliferate. 
If implantation takes place, endometrial cells secrete IL-15, which 
causes endometrial NK cells to differentiate into decidual NK cells. 
Decidual NK cells begin to increase the production of cytokines, 
growth factors, and angiogenetic factors [41] (Figure 6). 
Decidual NK cells increase blood flow at the fetomaternal interface 
by remodeling of spiral arteries and help migration of trophoblasts. 
Some angiogenetic factors (VEGF, PLGF, Angiopoietin-2, and NKG5) 
are produced by decidual NK cells. They also secret various cytokines 
and growth factors such as TNF-α, IL-10, GM-CSF, IL-1β, TGF-β1, CSF-
1, LIF, and IFN-γ [42]. Through this mechanism, decidual NK cells seem 
to contribute to embryo implantation and decidualization of the en-
dometrium (Figure 6) [41]. 
Several theories have been poposed for the origin of uterine NK cells. 
Among them, the most popular theory is the trafficking of peripheral 
blood NK cells. Endometrial chemokines have been suggested to re-
cruit periheral blood CD56
brightCD16
− NK cells into the uterus. TGF-β 
may convert CD56
+CD16
+ NK cells into CD56
brightCD16
− NK cells. Many 
chemokines are expressed in the human endometrium (CCL4, CCl5, 
CCl7, CCL13, CCL19, CCL21, CXCL9, CXCL10, IL-15). The chemokine re-
ceptors responding to these include CCR5, CCR7, CXCR3, CXCR4, and 
IL-15Rα chain [43]. Theories of in situ proliferation of uterine NK cells 
and of uterine NK cell differentiation from hematopoietic precursors 
have also been proposed [40].
Conclusion
The human endometrium undergoes significant changes to pre-
pare for implantation of an embryo during the peri-implantation pe-
riod. The immune cells also alter in number and function systemically 
and locally in the luteal phase. This modification of the reproductive 
and immune systems is profoundly influenced by several hormones, 
especially ovarian steroids. 
Recognition of pregnancy is essential for maternal tolerance of a fe-
tus. Although hCG is known as one of the candidates that may be in-
Figure 5. Number of NK cells in human endometrium or deciduae. 
The number of endometrial and decidual NK cells starts to increase 
in the mid-secretory phase and early pregnancy, reaches a peak at 
the end of the first trimester, and then decreases as the fetus ap-
proaches term (Modified from King A, et al. Dev Immunol 1991;1: 
169-90 [39]).
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volved in pregnancy recognition, recognition of trophoblast-driven 
products by immune cells also induces decidual differentiation of the 
endometrium. 
It is evident that an encounter of immune cells with paternal and/
or fetal antigens is essential to achieve maternal immune tolerance. 
Many innate and adaptive immune cells seem to play a significant 
role in establishment and maintenance of pregnancy. This prepara-
tion of the endometrium and immune system for pregnancy begins 
before the implantation occurs. As a result, significant biologic and 
immune modifications have already taken place before the window 
of implantation. This process is regulated by the complicated and 
delicate interaction of the endocrine-immune system. 
Further studies are warranted to solve the enigma of the establish-
ment of implantation and maintenance of successful pregnancy.
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